A Trial of TTI-621 in Combination With Doxorubicin in Patients With Leiomyosarcoma
Condition: Leiomyosarcoma Interventions: Drug: TTI-621; Drug: Doxorubicin Sponsor: Trillium Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Leiomyosarcoma | Research